Item 8.01. Other Events.
On March 3, 2021, Agilent Technologies, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $850 million in aggregate principal amount of its 2.300% Senior Notes due 2031 (the “Notes”) in an underwritten public offering (the “Offering”). The Offering is expected to close on March 12, 2021, subject to customary closing conditions. The Underwriting Agreement contains customary representations and covenants and includes the terms and conditions of the sale of the Notes, indemnification and contribution obligations and other terms and conditions customary in agreements of this type.
The Notes will be issued pursuant to a base indenture, expected to be dated as of March 12, 2021, between the Company and Citibank, N.A., as trustee (the “Trustee”), as supplemented by a first supplemental indenture thereto, expected to be dated as of March 12, 2021, between the Company and the Trustee.
The Notes will be issued at a price to the public of 99.822% of their principal amount. The Notes will mature on March 12, 2031 and bear interest at a fixed rate of 2.300% per annum, payable semi-annually in arrears on March 12 and September 12 of each year, commencing on September 12, 2021. The Notes will be unsecured and will rank equally in right of payment with all of the Company’s other senior unsecured indebtedness.
The Notes are being offered pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-233593) filed with the Securities and Exchange Commission on September 3, 2019, as supplemented by the prospectus supplement, dated March 3, 2021. In connection with the Offering, the Company is filing the Underwriting Agreement as Exhibit No. 1.1 to this Current Report on Form 8-K. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.
A copy of the legal opinion of Goodwin Procter LLP relating to the legality of the issuance and sale of the Notes in the Offering is attached as Exhibit 5.1 to this Current Report on Form 8-K.
On March 3, 2021, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
On March 5, 2021, the Company elected to call for full redemption of its $300 million outstanding 3.20% Senior Notes due September 2022 (the “2022 Notes”) and a notice of redemption has been sent to all registered holders of the 2022 Notes. The redemption price for the 2022 Notes is equal to the present value of the remaining scheduled principal and interest payments on the notes (excluding interest accrued to, but not including, the redemption date), as determined in accordance with the supplemental indenture relating to the 2022 Notes, on the third business day prior to the redemption date, plus accrued and unpaid interest to, but excluding, April 5, 2021, which is the date of redemption.